Ignite Creation Date:
2025-12-24 @ 6:43 PM
Ignite Modification Date:
2026-01-18 @ 5:38 PM
Study NCT ID:
NCT02966457
Status:
COMPLETED
Last Update Posted:
2017-12-28
First Post:
2016-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of DEcolonization in Patients With HAematological Malignancies (DEHAM)
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'submissionTracking': {'submissionInfos': [{'resetDate': '2018-09-24', 'releaseDate': '2018-01-08'}, {'resetDate': '2023-07-17', 'releaseDate': '2022-08-28'}], 'estimatedResultsFirstSubmitDate': '2018-01-08'}}, 'interventionBrowseModule': {'meshes': [{'id': 'C004691', 'term': 'colistinmethanesulfonic acid'}, {'id': 'D003091', 'term': 'Colistin'}], 'ancestors': [{'id': 'D011113', 'term': 'Polymyxins'}, {'id': 'D010456', 'term': 'Peptides, Cyclic'}, {'id': 'D047028', 'term': 'Macrocyclic Compounds'}, {'id': 'D011083', 'term': 'Polycyclic Compounds'}, {'id': 'D055666', 'term': 'Lipopeptides'}, {'id': 'D008055', 'term': 'Lipids'}, {'id': 'D023181', 'term': 'Antimicrobial Cationic Peptides'}, {'id': 'D010455', 'term': 'Peptides'}, {'id': 'D000602', 'term': 'Amino Acids, Peptides, and Proteins'}, {'id': 'D000089882', 'term': 'Antimicrobial Peptides'}, {'id': 'D052899', 'term': 'Pore Forming Cytotoxic Proteins'}, {'id': 'D008565', 'term': 'Membrane Proteins'}, {'id': 'D011506', 'term': 'Proteins'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE4'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'PREVENTION', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 62}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2017-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-12', 'completionDateStruct': {'date': '2017-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-12-26', 'studyFirstSubmitDate': '2016-11-15', 'studyFirstSubmitQcDate': '2016-11-15', 'lastUpdatePostDateStruct': {'date': '2017-12-28', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2016-11-17', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2017-12', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Rate of eradication of ESBL-producing or carbapenem-resistant Enterobacteriaceae, carbapenem-resistant A. baumannii or P. aeruginosa at day 21 post-treatment', 'timeFrame': '21 days'}], 'secondaryOutcomes': [{'measure': 'Rate of resistance of isolated on day 21 post-treatment Enterobacteriaceae, A. baumannii, P. aeruginosa to polymyxin antibiotics', 'timeFrame': '21 days'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['hematological infection, decolonization'], 'conditions': ['Hematological Infection']}, 'referencesModule': {'references': [{'pmid': '27382554', 'type': 'BACKGROUND', 'citation': 'Stoma I, Karpov I, Milanovich N, Uss A, Iskrov I. Risk factors for mortality in patients with bloodstream infections during the pre-engraftment period after hematopoietic stem cell transplantation. Blood Res. 2016 Jun;51(2):102-6. doi: 10.5045/br.2016.51.2.102. Epub 2016 Jun 23.'}, {'pmid': '26511929', 'type': 'BACKGROUND', 'citation': 'Rieg S, Kupper MF, de With K, Serr A, Bohnert JA, Kern WV. Intestinal decolonization of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature. BMC Infect Dis. 2015 Oct 28;15:475. doi: 10.1186/s12879-015-1225-0.'}, {'pmid': '29755707', 'type': 'DERIVED', 'citation': 'Stoma I, Karpov I, Iskrov I, Krivenko S, Uss A, Vlasenkova S, Lendina I, Cherniak V, Suvorov D. Decolonization of Intestinal Carriage of MDR/XDR Gram-Negative Bacteria with Oral Colistin in Patients with Hematological Malignancies: Results of a Randomized Controlled Trial. Mediterr J Hematol Infect Dis. 2018 May 1;10(1):e2018030. doi: 10.4084/MJHID.2018.030. eCollection 2018.'}]}, 'descriptionModule': {'briefSummary': 'MDR (multidrug resistant) gram-negative bacteria have emerged as an important cause of bloodstream infection in hospitalized patients, especially in immunocompromised hosts. It was previously shown, that intestinal colonization with extended-spectrum β-lactamases (ESBL)-producing or carbapenem-resistant Enterobacteriaceae, carbapenem-resistant A. baumannii and P. aeruginosa) is a clinical predictor of bloodstream infections in patients with haematological malignancies and/or haematopoietic stem cell transplantation \\[Stoma I. et al., 2016\\].\n\nTo the investigators knowledge no randomized, placebo-controlled clinical trial has been performed to study the efficacy and safety of selective intestinal decolonization strategies in high-risk patients with haematological malignancies. Possible decolonization of MDR gram-negative bacteria in haematological patients could be important for the patient by reducing the risk of infection and for the community by reducing the risk of transmission.\n\nThe purpose of the proposed study is to assess the efficacy and safety of selective intestinal decolonization of MDR gram-negative bacteria with oral administration of Colistimethate sodium in high risk patients with haematological malignancies.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. Microbiologically proven rectal carriage of ESBL-producing Enterobacteriaceae or carbapenem-resistant Enterobacteriaceae, A. baumannii, P. aeruginosa without signs and symptoms of active infection.\n2. Patient must give written informed consent to participate in the study. The informed consent can be given by the legal representative if necessary.\n\nExclusion Criteria:\n\n1. Active bacterial, viral, fungal or protozoal infection\n2. Women who are pregnant or nursing\n3. Antibacterial therapy in previous 10 days\n4. Contraindication to the use of one of the study drugs (including known hypersensitivity)\n5. Patient already enrolled in another study, or in the present study for a previous episode\n6. Psychiatric disorder or unable to understand or to follow the protocol directions\n7. Resistance of the primarily isolated colonizing microorganism to polymyxin antibiotics proven by methods of polymerase chain reaction'}, 'identificationModule': {'nctId': 'NCT02966457', 'acronym': 'DEHAM', 'briefTitle': 'A Study of DEcolonization in Patients With HAematological Malignancies (DEHAM)', 'organization': {'class': 'OTHER_GOV', 'fullName': 'Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology'}, 'officialTitle': 'A Randomized Clinical Study of the Decolonization of MDR Gram-negative Bacteria in Patients With Haematological Malignancies', 'orgStudyIdInfo': {'id': 'HEM-3_1'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Selective intestinal decolonization', 'description': 'Drug: Decolonization with Colistimethate sodium (2 mln I.U. 4x/day PO) for 14 days', 'interventionNames': ['Drug: Colistimethate Sodium']}, {'type': 'NO_INTERVENTION', 'label': '"Wait and watch" strategy', 'description': 'Group without decolonization interventions'}], 'interventions': [{'name': 'Colistimethate Sodium', 'type': 'DRUG', 'otherNames': ['Colistin'], 'description': 'Selective oral intestinal decolonization', 'armGroupLabels': ['Selective intestinal decolonization']}]}, 'contactsLocationsModule': {'locations': [{'zip': '220045', 'city': 'Minsk', 'country': 'Belarus', 'facility': 'Republican Center of Hematology and Bone Marrow Transplantation', 'geoPoint': {'lat': 53.90019, 'lon': 27.56653}}], 'overallOfficials': [{'name': 'Ihar Iskrou, Ph.D.', 'role': 'STUDY_CHAIR', 'affiliation': 'Republican Center of Hematology and Bone Marrow Transplantation'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology', 'class': 'OTHER_GOV'}, 'collaborators': [{'name': 'Belarusian State Medical University', 'class': 'OTHER'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Head of Cell Transplant Division', 'investigatorFullName': 'Ihar Iskrou', 'investigatorAffiliation': 'Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology'}}}, 'annotationSection': {'annotationModule': {'unpostedAnnotation': {'unpostedEvents': [{'date': '2018-01-08', 'type': 'RELEASE'}, {'date': '2018-09-24', 'type': 'RESET'}, {'date': '2022-08-28', 'type': 'RELEASE'}, {'date': '2023-07-17', 'type': 'RESET'}], 'unpostedResponsibleParty': 'Igor Stoma, Head of Cell Transplant Division, Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology'}}}}